Blood Reviews
Volume 20, Issue 2 , Pages 83-92, March 2006

Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease

The Katharine Dormandy Haemophilia Centre & Haemostasis Unit, Royal Free and University College Medical School, Pond Street, London NW3 2QG, UK

published online 29 March 2005.

Summary 

Oligosaccharides make up approximately 20% of the mass of VWF and although their structures are well established, their functional role remains unclear. Modification of the VWF oligosaccharide structures has been shown to result in increased plasma clearance of the protein. A mutation which alters cell type-specific expression of the Galgt2 glycosyltransferase gene in the RIIIS/J mouse results in an autosomal dominant partial quantitative deficiency of VWF. Increased plasma clearance of VWF has been demonstrated in some individuals with a partial quantitative deficiency of the protein and it is possible that variation in VWF glycosylation may contribute towards this. ABH antigens occur within the oligosaccharide component of VWF and may account for the variation in plasma VWF:Ag levels observed between individuals of different ABO blood groups. The structures and functional roles of the oligosaccharide side chains of VWF and possible pathogenetic mechanisms by which they may contribute towards VWD are reviewed in this article.

Keywords: Von Willebrand disease, Von Willebrand Factor, Oligosaccharide, ABO blood group, ADAMTS13, RIIIS/J mouse, Clearance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0268-960X(05)00020-2

doi:10.1016/j.blre.2005.02.002

Blood Reviews
Volume 20, Issue 2 , Pages 83-92, March 2006